Is Asparaginase Encapsulated in Erythrocytes Effective As Second-line Treatment in Acute Lymphoblastic Leukaemia?

Overview

Journal Br J Haematol

Specialty Hematology

Date 2022 Jul 20

PMID 35857756

Authors

Inge M van der Sluis

Yves Bertrand

Andre Baruchel

Rob Pieters

Affiliations

Soon will be listed here.

Citing Articles

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.

Ding J, Ding X, Liao W, Lu Z Mater Today Bio. 2024; 24:100913.

PMID: 38188647 PMC: 10767221. DOI: 10.1016/j.mtbio.2023.100913.

References

Rizzari C, Zucchetti M, Conter V, Diomede L, Bruno A, Gavazzi L . L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure. Ann Oncol. 2000; 11(2):189-93. DOI: 10.1023/a:1008368916800. View

Ballerini A, Moro F, Fuso Nerini I, Marzo C, Di Clemente A, Ferrari M . Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations. Cancer Chemother Pharmacol. 2017; 79(6):1267-1271. DOI: 10.1007/s00280-017-3307-8. View

Rizzari C, Lanvers-Kaminsky C, Valsecchi M, Ballerini A, Matteo C, Gerss J . Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study. Haematologica. 2019; 104(9):1812-1821. PMC: 6717578. DOI: 10.3324/haematol.2018.206433. View

Domenech C, Thomas X, Chabaud S, Baruchel A, Gueyffier F, Mazingue F . l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial. Br J Haematol. 2011; 153(1):58-65. DOI: 10.1111/j.1365-2141.2011.08588.x. View

Hunault-Berger M, Leguay T, Huguet F, Lepretre S, Deconinck E, Ojeda-Uribe M . A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study. Am J Hematol. 2015; 90(9):811-8. DOI: 10.1002/ajh.24093. View

van der Sluis I, Vrooman L, Pieters R, Baruchel A, Escherich G, Goulden N . Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica. 2016; 101(3):279-85. PMC: 4815719. DOI: 10.3324/haematol.2015.137380. View

Lanvers-Kaminsky C, Westhoff P, DIncalci M, Zucchetti M, Boos J . Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase. Ther Drug Monit. 2013; 36(4):549-52. DOI: 10.1097/FTD.0000000000000030. View

Stensig Lynggaard L, Vaitkeviciene G, Langenskiold C, Lehmann A, Lahteenmaki P, Lepik K . Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia. Br J Haematol. 2022; 197(6):745-754. DOI: 10.1111/bjh.18152. View

van der Sluis I, de Groot-Kruseman H, Te Loo M, Tissing W, van den Bos C, Kaspers G . Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group. Pediatr Blood Cancer. 2018; 65(8):e27083. DOI: 10.1002/pbc.27083. View

10.

Henriksen L, Nersting J, Raja R, Frandsen T, Rosthoj S, Schroder H . Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia. Br J Haematol. 2014; 166(2):213-20. DOI: 10.1111/bjh.12865. View

11.

Riccardi R, Holcenberg J, Glaubiger D, WOOD J, Poplack D . L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981; 41(11 Pt 1):4554-8. View